VisEn offers new fluorescence imaging options, enables multi-modal fusion
April 23, 2009
APRIL 23, 2009--During the just-concluded 100th Annual Meeting of the American Association of Cancer Research (AACR, April 18-22, Denver, CO), VisEn Medical Inc. (Bedford, MA), introduced its new FAST ("Fluorescent Activatible Sensor Technology") imaging agent platform for advanced imaging of key disease-associated biomarkers and drug response in vivo.
Sponsored Recommendations
Sponsored Recommendations
How to Tune Servo Systems: Force Control
Oct. 23, 2024
Voice your opinion!
Voice your opinion!